OBiO Technology (Shanghai) Corp. Ltd. A
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing pr… Read more
Market Cap & Net Worth: OBiO Technology (Shanghai) Corp. Ltd. A (688238)
OBiO Technology (Shanghai) Corp. Ltd. A (SHG:688238) has a market capitalization of $670.51 Million (CN¥4.92 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #10639 globally and #2392 in its home market, demonstrating a 3.41% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OBiO Technology (Shanghai) Corp. Ltd. A's stock price CN¥7.58 by its total outstanding shares 649036700 (649.04 Million).
OBiO Technology (Shanghai) Corp. Ltd. A Market Cap History: 2022 to 2026
OBiO Technology (Shanghai) Corp. Ltd. A's market capitalization history from 2022 to 2026. Data shows change from $1.30 Billion to $670.51 Million (-18.20% CAGR).
OBiO Technology (Shanghai) Corp. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OBiO Technology (Shanghai) Corp. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.76x
OBiO Technology (Shanghai) Corp. Ltd. A's market cap is 1.76 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.30 Billion | $291.30 Million | $39.26 Million | 4.45x | 33.04x |
| 2023 | $795.24 Million | $204.81 Million | -$127.94 Million | 3.88x | N/A |
| 2024 | $436.98 Million | $248.15 Million | -$321.81 Million | 1.76x | N/A |
Competitor Companies of 688238 by Market Capitalization
Companies near OBiO Technology (Shanghai) Corp. Ltd. A in the global market cap rankings as of March 18, 2026.
Key companies related to OBiO Technology (Shanghai) Corp. Ltd. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
OBiO Technology (Shanghai) Corp. Ltd. A Historical Marketcap From 2022 to 2026
Between 2022 and today, OBiO Technology (Shanghai) Corp. Ltd. A's market cap moved from $1.30 Billion to $ 670.51 Million, with a yearly change of -18.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥670.51 Million | +13.81% |
| 2025 | CN¥589.13 Million | +34.82% |
| 2024 | CN¥436.98 Million | -45.05% |
| 2023 | CN¥795.24 Million | -38.68% |
| 2022 | CN¥1.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of OBiO Technology (Shanghai) Corp. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $670.51 Million USD |
| MoneyControl | $670.51 Million USD |
| MarketWatch | $670.51 Million USD |
| marketcap.company | $670.51 Million USD |
| Reuters | $670.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.